| 1 |
31748533 | Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors. | 2019 Nov 20 |
1 |
| 2 |
30158927 | Tissue-Specific Roles of NKT Cells in Tumor Immunity. | 2018 |
1 |
| 3 |
28526683 | Autoreactivity to Sulfatide by Human Invariant NKT Cells. | 2017 Jul 1 |
1 |
| 4 |
25014535 | Synthesis of a 2"-deoxy-β-GalCer. | 2014 Jul 10 |
2 |
| 5 |
25261475 | Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease. | 2014 Nov 1 |
2 |
| 6 |
24239091 | Crystal structure of Vδ1 T cell receptor in complex with CD1d-sulfatide shows MHC-like recognition of a self-lipid by human γδ T cells. | 2013 Dec 12 |
1 |
| 7 |
22247226 | Sulfatide inhibits α-galactosylceramide presentation by dendritic cells. | 2012 Feb |
3 |
| 8 |
22820603 | Recognition of CD1d-sulfatide mediated by a type II natural killer T cell antigen receptor. | 2012 Sep |
3 |
| 9 |
22829134 | The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR. | 2012 Sep |
3 |
| 10 |
23550344 | Sulfatide--a new candidate for ART treatment in HIV-1 infection. | 2012 |
1 |
| 11 |
20861926 | Sulfatide administration leads to inhibition of HIV-1 replication and enhanced hematopoeisis. | 2010 |
2 |